The objectives of these studies were to study the effects of six, age, strain, and environmental chemicals on cytochrome P-450 enzymes and relate these changes to the ability of the liver to metabolize steroids and foreign compounds. 1. Cytochrome P-450g is highly variable in outbred CD rats (high and low populations) and absent in the Fischer rat. It is male specific and found only after puberty. This enzyme metabolizes steroids but there were no significant differences in steroid hydroxylation between high and low phenotypes of CD rats. 2. Cytochrome P-450 UT-H (debrisoquine form) and cytochrome P-450 2c (a male specific isozyme) were decreased (40% and 90%) by a toxic PCB isomer, and to a lesser extent by 3-MC and phenobarbital. Metabolism of testosterone by liver microsomes (P-4502c mediated) at the 2- and 16- positions was also decreased dramatically. Decreases in 6Beta-hydroxylation of testosterone and increases in 7Alpha-hydroxylation also occurred, and may be involved in changes in endocrine status of the PCB exposed rat. 3. The possible binding of hexachlorobenzene to the Ah receptor and its induction of P1-450 and P3-450 is being investigated. Some evidence for involvement of the Ah locus in the action of hexachlorobenzene is indicated. The goal of this project is to better understand changes in the ability of the liver to metabolize hormones and foreign chemicals after exposure to environmental chemicals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES021024-05
Application #
3965181
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
U.S. National Inst of Environ Hlth Scis
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Makia, Ngome L; Goldstein, Joyce A (2016) CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor ? in Human Liver. Mol Pharmacol 89:154-64
Makia, Ngome L; Surapureddi, Sailesh; Monostory, Katalin et al. (2014) Regulation of human CYP2C9 expression by electrophilic stress involves activator protein 1 activation and DNA looping. Mol Pharmacol 86:125-37
Langaee, Taimour Y; Zhu, Hao-Jie; Wang, Xinwen et al. (2014) The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping. Pharmacogenet Genomics 24:381-6
Shi, Zhe; Yang, Wenjun; Goldstein, Joyce A et al. (2014) Med25 is required for estrogen receptor alpha (ER?)-mediated regulation of human CYP2C9 expression. Biochem Pharmacol 90:425-31
Chen, Yuping; Coulter, Sherry; Jetten, Anton M et al. (2009) Identification of human CYP2C8 as a retinoid-related orphan nuclear receptor target gene. J Pharmacol Exp Ther 329:192-201
Delozier, Tracy C; Kissling, Grace E; Coulter, Sherry J et al. (2007) Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35:682-8
Lee, Su-Jun; van der Heiden, Ilse P; Goldstein, Joyce A et al. (2007) A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system. Drug Metab Dispos 35:67-71
Lee, Su-Jun; Perera, Lalith; Coulter, Sherry J et al. (2007) The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system. Pharmacogenet Genomics 17:169-80
Parikh, S; Ouedraogo, J-B; Goldstein, J A et al. (2007) Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther 82:197-203
Vyas, Piyush M; Roychowdhury, Sanjoy; Khan, Farah D et al. (2006) Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450. J Pharmacol Exp Ther 319:488-96

Showing the most recent 10 out of 37 publications